Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic model
Jie Fang(St. Jude Children's Research Hospital), Jun J. Yang(St. Jude Children's Research Hospital), Jacob Steele(St. Jude Children's Research Hospital), Ahmed Abu-Zaid(St. Jude Children's Research Hospital), Yiping Fan(St. Jude Children's Research Hospital), Jerold E. Rehg(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital), John Easton(St. Jude Children's Research Hospital), Changde Cheng(St. Jude Children's Research Hospital), Shivendra V. Singh(St. Jude Children's Research Hospital), Joseph Emmons(St. Jude Children's Research Hospital), Jon P. Connelly(St. Jude Children's Research Hospital), Adam D. Durbin(St. Jude Children's Research Hospital), Wenan Chen(St. Jude Children's Research Hospital), Hongjian Jin(St. Jude Children's Research Hospital), Andrew M. Davidoff(Unknown), Stefano Cairo, Andrew J. Murphy(St. Jude Children's Research Hospital), Ruoning Wang(Nationwide Children's Hospital), HaWon Lee(St. Jude Children's Research Hospital), Evan S. Glazer(University of Tennessee Health Science Center), Xiang Chen(Microsoft (United States)), Qiong Wu(Harbin Institute of Technology), Sivaraman Natarajan(St. Jude Children's Research Hospital), Heather Tillman(St. Jude Children's Research Hospital), Taosheng Chen(St. Jude Children's Research Hospital)
Cited by 2
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Germline Mutations in Predisposition Genes in Pediatric Cancer
|New England Journal of Medicine|2015|1.4k
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
|New England Journal of Medicine|2014|1.2k